Skip to main content

Day: January 9, 2025

Brunswick Exploration Drills 37 Meters at 1.14% Extending the MR-3 Dyke at the Mirage Project

MONTREAL, Jan. 09, 2025 (GLOBE NEWSWIRE) — Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; FRANKFURT: 1XQ; “BRW” or the “Company”) is pleased to report the last results from the Mirage summer drilling campaign. The Mirage Project is located in the Eeyou Istchee-James Bay region of Quebec, approximately 40 kilometers south of the Trans-Taiga Road. This campaign focused on the Central Zone including the MR-6 and MR-3 dykes (see October 8, 2024 press release) and has continued to intersect wide and well-mineralized intervals on their extension and at depth. Highlights include:37 meters at 1.14% Li2O in hole MR-24-87 and 1.15% Li2O over 23 meters in hole MR-24-89 extending mineralization at MR-3 down dip where it remains open. New interval at the MR-6 Dyke with 1.74% Li2O over 19.7 meters in hole MR-24-84 and 0.93% Li2O over...

Continue reading

Ultimovacs ASA: Notification of major holdings

Oslo, 9 January 2025: Reference is made to the stock exchange notices published by Ultimovacs ASA (the “Company“) on (i) 17 December 2024 regarding the contemplated business combination between the Company and Zelluna Immunotherapy AS (the “Business Combination“) and the fully committed private placement with gross proceeds of approx. NOK 51.7 million (the “Private Placement“) and (ii) today on 9 January 2025 regarding the approval by an extraordinary general meeting of the Company (the “EGM“) of relevant resolutions related to the Business Combination and the Private Placement. The Business Combination and the Private Placement are hereinafter referred to as the “Transactions“. Following the EGM’s resolutions to approve the issuance of 167,864,598 shares in aggregate through...

Continue reading

Teleflex awarded Short Term Central Venous Catheters contract from Vizient

Including market leading Arrow™ CVCs and Arterial Catheters WAYNE, Pa., Jan. 09, 2025 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has been awarded a contract by Vizient, Inc., the largest provider-driven healthcare performance improvement company in the U.S. The agreement, effective January 1, 2025, covers the supply of Teleflex’s Central Venous Access Catheters and Arterial Catheters. Vizient provides solutions and services that improve the delivery of high-value care by aligning cost, quality, and market performance for more than 65% of the nation’s acute care providers. This includes 97% of the nation’s academic medical centers, and more than 35% of the acute care market. Vizient provides expertise, analytics, and advisory services, as well...

Continue reading

Kaldalón hf.: Announcement from the Nomination Committee

The Nomination Committee of Kaldalón serves an advisory role in the selection of the Company’s Board of Directors and nominates candidates for board positions. Further details on the role of the Nomination Committee and its rules of procedure are available on Kaldalón’s website. The Nomination Committee of Kaldalón invites proposals for board members or declarations of candidacy for the upcoming Annual General Meeting of the company, scheduled for April 3, 2025. The committee requests that such information will be sent to the committee’s email address, tilnefningarnefnd@kaldalon.is, by 4:00 PM on January 31, 2025. Candidacies must include information on the candidacy form, which can be found on Kaldalón’s website. The above deadline does not restrict candidates’ right to submit candidacies within the timeframe stipulated...

Continue reading

Form 8.3 – [LOUNGERS PLC – 08 01 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary Clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree LOUNGERS PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing

Sharing Insights at the ‘Italy on the Move’ Event and Engaging Investors at Biotech Showcase During JPM Healthcare Week in San Francisco MILAN and NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) — Genenta Science (NASDAQ: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, is pleased to announce that it has strengthened its partnership with AGC Biologics, a global contract development and manufacturing organization (CDMO), by amending their Development and Master Services Agreement. This amendment introduces an exclusive GMP suite at the AGC Biologics Cell and Gene Center of Excellence in Milan, dedicated to the manufacturing of Genenta’s cell therapy product, ensuring compliance with cGMP standards. This strategic move enhances Genenta’s production capabilities, potentially improving efficiency and...

Continue reading

O2 Czech Republic Launches Allot Solution to Offer Consumer Cybersecurity Services

Hod Hasharon, Israel, Jan. 09, 2025 (GLOBE NEWSWIRE) — Allot Ltd. (NASDAQ: ALLT) (TASE: ALLT), a leading global provider of innovative network intelligence and converged network-native security solutions for communication service providers and enterprises, today announced that O2 Czech Republic, a subsidiary of the PPF Group, has launched Allot DNS Secure, enabling them to continue offering and enhance cybersecurity protection services to both their mobile and fixed broadband consumer customers. This service launch is the result of an agreement between Allot and O2 Czech Republic signed earlier this year, and of an umbrella agreement signed with O2 Czech Republic parent company PPF Group to supply cybersecurity solutions to the group’s telecom provider subsidiaries. Allot will benefit from a recurring monthly fee for cybersecurity...

Continue reading

Openreach chooses Nokia to build open-access fiber network to connect millions to faster broadband

Press ReleaseOpenreach chooses Nokia to build open-access fiber network to connect millions to faster broadbandNokia building open access platform to accelerate fiber broadband services for millions of UK homes and businesses. Nokia’s intent-based model enables Openreach to reduce operations support systems (OSS) complexity by 85%. Nokia’s domain controllers allow Openreach to fully automate and simplify network operations, driving scalability and operational efficiency throughout its network.9 January 2025Espoo, Finland – Nokia today announced it has been chosen by Openreach to build its One Network Platform, an open-access fiber network to serve millions of homes and businesses. Built using Nokia’s Altiplano and NSP network domain controllers, the network will help Openreach grow from 17 million connected premises today to 25 million...

Continue reading

Correction: Final terms for bonds to be listed 10th January 2025

To Nasdaq Copenhagen A/S                        9th January 2025                                        Announcement no. 3/2025 CORRECTION: ISIN DK0009416893 is a Realkreditobligation (RO) Final terms for bonds to be listed 10th January 2025 On 10th January 2025, Jyske Realkredit A/S will be listing new Covered Bonds (SDO). Final terms for the bonds are attached to this announcement. The full prospectus for the Bonds consist of the attached final terms and the previously disclosed ”Base Prospectus for the issue of Covered Bonds (SDO), Mortgage bonds (“RO”) and Mortgage Bonds (RO) and bonds issued pursuant to Section 15 of the Danish Mortgage-Credit Loans and Mortgage-Credit Bonds etc. Act (Section 15 Bonds).”, dated June 28th, 2024. Jyske Realkredit’s base prospectus is available on Jyske Realkredit’s home page jyskerealkredit.com Yours...

Continue reading

Share Buyback Transaction Details January 2 – January 8, 2025

PRESS RELEASE                                         Share Buyback Transaction Details January 2 – January 8, 2025 Alphen aan den Rijn – January 9, 2025 – Wolters Kluwer (Euronext: WKL), a global leader in professional information, software solutions, and services, today reports that it has repurchased 82,234 of its own ordinary shares in the period from January 2, 2025, up to and including January 8, 2025, for €13.2 million and at an average share price of €160.00. These repurchases are part of the share buyback program announced on October 30, 2024, under which we intend to repurchase shares for €100 million during the period starting January 2, 2025, up to and including February 24, 2025. The cumulative amounts repurchased in the year to date under this program are as follows: Share Buyback 2025Period Cumulative shares repurchased...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.